Jushi HoldingsJUSHF -1.13%47 EBITDA Margin % is 10.98% as of Mar. 2026, which is 15% below its 10-year median of 12.99. GuruFocus rates JUSHF with a GF Score™ of 47/100 and a GF Value™ of $0.51 (Fairly Valued). The stock has 5 warning signs investors should review. Among 952 Drug Manufacturers companies, Jushi Holdings ranks better than 52.42% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Jushi Holdings's EBITDA for the
three
months ended in Mar. 2026 was $7.3 Mil. Jushi Holdings's Revenue for the
three
months ended in Mar. 2026 was $66.4 Mil. Therefore, Jushi Holdings's EBITDA margin for the quarter that ended in Mar. 2026 was 10.98%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jushi Holdings EBITDA Margin % Related Terms
Jushi Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Jushi Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jushi Holdings (JUSHF) has a EBITDA Margin % of 10.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jushi Holdings and its competitors. This is 15% below median its historical median of 12.99. According to the industry distribution chart, Jushi Holdings ranks #453 out of 952 companies in the Drug Manufacturers industry, placing it in the top 47.6%.
Is Jushi Holdings' EBITDA Margin % too high?
Jushi Holdings' current EBITDA Margin % of 10.98% is 15% below median its 10-year median of 12.99. The Drug Manufacturers industry median EBITDA Margin % is 12.47. Jushi Holdings' value of 10.98% is 11.9% below this industry median. Based on the distribution chart, Jushi Holdings ranks #453 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #453 out of 952 companies for EBITDA Margin %. This puts Jushi Holdings in the upper half of its industry. The industry median EBITDA Margin % is 12.47. Jushi Holdings' value of 10.98% is 11.9% below this benchmark. While the company's 10-year median is 12.99 vs. the industry median of 12.47, Jushi Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current EBITDA Margin % of 10.98% is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current EBITDA Margin % is 10.98%, which is 15% below median its own 10-year median of 12.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.51, compared to a current price of $0.48 — trading 6% below its estimated fair value. The current EBITDA Margin % is 10.98%, which is 15% below median its 10-year median of 12.99 and 11.9% below the Drug Manufacturers industry median of 12.47. Jushi Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jushi Holdings (JUSHF), the current EBITDA Margin % is 10.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.48 is trading 6% below its estimated GF Value™ of $0.51.
GuruFocus considers Jushi Holdings to be Fairly Valued.
Key valuation signals for JUSHF:
EBITDA Margin %: 10.98% (15% below median its 10-year median of 12.99)
GF Value™: $0.51 vs. price of $0.48 (6% below fair value)
Industry Position: 11.9% below the Drug Manufacturers median (#453 of 952)
No single metric tells the full story. See the JUSHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
47GF Score
Get the complete analysis for JUSHF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSHF has been successfully added to your 
